Cargando…
Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders
Fragile X syndrome (FXS) is the most common form of monogenic hereditary cognitive impairment. FXS patient exhibit a high comorbidity rate with autism spectrum disorders (ASDs). This makes FXS a model disease for understanding how synaptic dysregulation alters neuronal excitability, learning and mem...
Autor principal: | Telias, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417395/ https://www.ncbi.nlm.nih.gov/pubmed/30899214 http://dx.doi.org/10.3389/fnmol.2019.00051 |
Ejemplares similares
-
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
por: Wang, Hansen, et al.
Publicado: (2015) -
Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders
por: De Rubeis, Silvia, et al.
Publicado: (2011) -
Cytogenetic abnormalities and fragile-x syndrome in Autism Spectrum Disorder
por: Reddy, Kavita S
Publicado: (2005) -
Editorial: Recent advances in mechanisms and therapeutics for Fragile X Syndrome and autism
por: Molinaro, Gemma, et al.
Publicado: (2023) -
Transcranial Magnetic Stimulation Provides Means to Assess Cortical Plasticity and Excitability in Humans with Fragile X Syndrome and Autism Spectrum Disorder
por: Oberman, Lindsay, et al.
Publicado: (2010)